Long-term use of thiazide diuretics — a hypertension medication — may lower the risk of bone fractures, particularly hip…
Patricia Inacio, PhD
Patricia holds her PhD in cell biology from the University Nova de Lisboa, Portugal, and has served as an author on several research projects and fellowships, as well as major grant applications for European agencies. She also served as a PhD student research assistant in the Department of Microbiology & Immunology, Columbia University, New York, for which she was awarded a Luso-American Development Foundation (FLAD) fellowship.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Patricia Inacio, PhD
Blood levels of a nerve cell-derived component, known as neurofilament light chain, could be used as a biomarker of disease…
Cognitive Training Improves Reasoning and Memory in Adults with Mild Impairment, Pilot Study Finds
Cognitive training alone — without the use of direct brain stimulation — may significantly benefit adults with mild cognitive impairment,…
While caregiving for people with Alzheimer’s and other disorders has a significant detrimental impact on caregivers’ immune system, the association…
A Phase 1 trial evaluating Samumed’s investigational compound SM07883 for Alzheimer’s disease has dosed its first participant. The Phase…
The investigational therapy azeliragon decreased inflammation and lessened cognitive decline and dementia in patients with mild Alzheimer’s disease and type…
United Neuroscience’s vaccine candidate UB-311 was safe and well-tolerated in patients with mild Alzheimer’s disease, according to results…
Antiviral Medicine Could Help Halt Cognitive Decline in Early Alzheimer’s, Preliminary Data Show
Preliminary data from a Phase 2 study suggests that treating early Alzheimer’s disease patients who are positive for herpes simplex…
Alzinova‘s ALZ-101 vaccine — designed to target toxic forms of the amyloid beta protein that drive neurodegeneration in Alzheimer’s…
Neurotrope Bioscience announced that dosing of patients has started in its Phase 2 clinical trial to further evaluate Bryostatin-1,…